Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05606783 · ClinicalTrials.gov registry record · NA
Using Bluetooth Home Blood Pressure Monitors With Pharmacist Interventions
A NA study, sponsored by University of South Florida.
- Completed
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT05606783: Completed NA study, sponsored by University of South Florida.
NCT05606783 is a NA study that has completed, run by University of South Florida. The registered enrollment target is 9 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05606783, a NA study, has completed, sponsored by University of South Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
Family Medicine patients with uncontrolled hypertension will be given a Bluetooth enabled home blood pressure machine to monitor their blood pressure every day for 6 weeks. The blood pressure results will be sent automatically to the patient's electronic medical record via applications on their iPhone. Study pharmacists will follow-up with the patients once per week via a telehealth appointment using the app VSee, where the blood pressure results will be reviewed. The pharmacists will also counsel the patients on lifestyle modifications in order to improve blood pressure.
Primary Outcome
Patient comfort in using home telemonitoring for blood pressure combined with pharmacist counseling and monitoring will be measured using a survey instrument with a Likert scale (4-point scale). (Most of the time; Some of the time; Seldom; Never) (Strongly agree; Agree; Disagree; Strongly disagree) (Nothing; Very little; Some; Knowledgeable)
Interventions
- BEHAVIORAL Surveys
- BEHAVIORAL Telehealth Follow-up Visits
- DEVICE Devices
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2019-01-23 |
| Est. Completion | 2019-06-30 |
| Phase | NA |
What the finished NCT05606783 record still lists
NCT05606783 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 3 interventions - of which Surveys is the first listed.
NCT05606783 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05606783 about?
NCT05606783 is a clinical study titled "Using Bluetooth Home Blood Pressure Monitors With Pharmacist Interventions". Family Medicine patients with uncontrolled hypertension will be given a Bluetooth enabled home blood pressure machine to monitor their blood pressure every day for 6 weeks. The blood pressure results will be sent automatically to the patient's electronic medical record via applications on their iPho...
What is the current status of trial NCT05606783?
This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2019-01-23. Estimated completion is 2019-06-30.
What interventions are being tested in trial NCT05606783?
The interventions under investigation include: Surveys (BEHAVIORAL), Telehealth Follow-up Visits (BEHAVIORAL), Devices (DEVICE).
Who is sponsoring clinical trial NCT05606783?
This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05606783's enrollment target sits among peer trials
9 1975th of 2000 higher than 25 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI